Frozen Shoulder Treatment Market Growth, Size, Share, Trends, and Forecast 2032

Frozen Shoulder Treatment Market

Frozen Shoulder Treatment Market By treatment type (medication, surgery, physical treatment, and joint distension), By route of administration (Oral and Parental), By end-user (Hospitals, Homecare, and Specialty Clinics) And By Region: - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts, 2024-2032

Category: Medical Device Report Format : PDF Report Code: ZMR-5520 Status : Upcoming
Market Size in 2023 Market Forecast in 2032 Growth Rate (in %) Base Year
USD 2,580.83 Million USD 4,072.87 Million CAGR at 5.20% 2023

Frozen Shoulder Treatment Market

Description

Frozen Shoulder Treatment Market Insights

According to the report published by Zion Market Research, the global Frozen Shoulder Treatment Market size was valued at USD 2,580.83 Million in 2023 and is predicted to reach USD 4,072.87 Million by the end of 2032. The market is expected to grow with a CAGR of 5.20% during the forecast period. The report analyzes the global Frozen Shoulder Treatment Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Frozen Shoulder Treatment Market industry.

Global Frozen Shoulder Treatment Market SizeRequest Free Sample

Frozen Shoulder Treatment Market : Overview

Frozen shoulder is the common term for adhesive capsulitis and this is the shoulder condition that restricts the motion. In frozen shoulder condition, the tissues of the shoulder joint has become tight and thick and scar tissue is created within a specified time. The most common symptoms of frozen shoulder are stiffness, swelling, and pain. In addition to this, reduction in the shoulder movement is predicted to increase the stiffness in shoulders.  An elongated period of inactivity as a result of injury, surgery, and illness also increases susceptibility to inflammation & adhesion that are bands of stiff tissues.

Frozen Shoulder Treatment Market: Growth Drivers

Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan.

Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years. Massive investments in research activities pertaining to frozen shoulder therapy are projected to create lucrative growth avenues for the market over the forecast timeline.

Frozen Shoulder Treatment MarketRequest Free Sample

Frozen Shoulder Treatment Market: Segmentation

The global frozen shoulder treatment market can be classified based on treatment type, route of administration, end-user, and region.

In terms of treatment type, the frozen shoulder treatment industry is fragmented into medication, surgery, physical treatment, and joint distension.

On the basis of route of administration, the market is segregated into Oral and Parental.

End-User wise, the market is divided into Hospitals, Homecare, and Specialty Clinics. Region-wise, the market can be divided into the Middle East and Africa, North America, Latin America Asia Pacific, and Europe.

Frozen Shoulder Treatment Market: Report Scope

Report Attributes Report Details
Report Name Frozen Shoulder Treatment Market Research Report
Market Size in 2023 USD 2,580.83 Million
Market Forecast in 2032 USD 4,072.87 Million
Growth Rate CAGR of 5.20%
Number of Pages 201
Key Companies Covered GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp.
Segments Covered By treatment type, By route of administration, By end-user and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Frozen Shoulder Treatment Market: Regional Analysis

North America is projected to contribute majorly towards overall market earnings during the forecast timespan. The growth of the regional market over the estimated timeline can be credited to rise in the research activities along with launching of technologically advanced items by the giant firms. Apart from this, advanced treatment procedures for providing quick relief for the subjects suffering from frozen shoulder will prompt the regional market growth over the forecast timespan. Apparently, presence of giant firms in the countries like the U.S. and Canada will promote the regional growth trends.

Competitive Landscape

Key participants profiled in the study include:

  • GlaxoSmithKline plc
  • Vintage Pharma
  • Sun Pharmaceutical Industries Ltd
  • Glenmark Pharmaceuticals Ltd
  • Johnson & Johnson Services, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Contract Pharmacal Corp.

The Global Frozen Shoulder Treatment Market is segmented as follows:

By treatment type 

  • medication 
  • surgery 
  • physical treatment
  • joint distension

By route of administration 

  • Oral
  • Parental 

By end-user 

  • Hospitals
  • Homecare
  • Specialty Clinics

 Global Frozen Shoulder Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Surge in the aging populace prone to frozen shoulder is predicted to create massive scope for the market over the ensuing years. According to NIH (National Institutes of Health), the population with an age of 65 years and more across the U.S. is predicted to double over the coming three decades by end of 2050. Reportedly, the population aging 80 and more is set to triple by 2050 in the U.S. For the record, the population over the age of 80 years will quadruple by the end of 2050. In this way, the growth of the market is likely to be leaps & bounds over the forecast timespan. Furthermore, shoulder injuries are likely to result in frozen shoulder, thereby driving the business growth over the forecast timespan. Apparently, high risk of heart disorders and diabetes is likely to result in the frozen shoulder, thereby steering the expansion of frozen shoulder treatment industry over the forthcoming years.

The key players profiled in the report include GlaxoSmithKline plc, Vintage Pharma, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, and Contract Pharmacal Corp.

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed